Patrick S. Moore, MD, MPH is an American Cancer Society (ACS) and Distinguished Professor in the Department of Microbiology and Molecular Genetics, University of Pittsburgh. He is Director of the Cancer Virology Program for the University of Pittsburgh Cancer Institute and holds the Pittsburgh Foundation Chair in Innovative Cancer Research. Dr. Moore is recognized for his role, together with Dr. Yuan Chang -also an ACS Professor, in discovering and characterizing Kaposi sarcoma herpesvirus (KSHV or HHV8) and Merkel cell polyomavirus (MCV), the two most recently recognized human tumor viruses. Dr. Moore and Dr. Chang’s laboratory maintain an active focus on basic and translational research for both KSHV and MCV. Dr. Moore has received the General Motors Cancer Research Foundation Mott Prize, the Robert Koch Prize, the Meyenburg Cancer Research Prize, CDC-Langmuir Award, Paul Ehrlich Prize as well as other awards, is an elected member of the US National Academy of Science and other professional honor societies, and holds 23 patents. He is a Thomson Reuter ISI Highly Cited Researcher with over 32,000 scientific citations. He graduated from Westminster College in Salt Lake City, UT and received medical and graduate degrees from the University of Utah, Stanford University and University California, Berkeley and trained at the Centers for Disease Control as an Epidemic Intelligence Service (EIS) officer. In addition to his work on tumor viruses, he has expertise in refugee health and management and in control of meningococcal meningitis epidemics.